According to Regeneron Pharmaceuticals's latest financial reports the company's current earnings are A$13.84 Billion. In 2023 the company made an earning of A$6.49 Billion a decrease over its 2022 earnings that were of A$7.51 Billion. The earnings displayed on this page is the company's Pretax Income.